Role of PLSCR3 in Adipogenesis & Adipose Lipid Storage

PLSCR3 在脂肪形成中的作用

基本信息

  • 批准号:
    7123418
  • 负责人:
  • 金额:
    $ 24.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-30 至 2008-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Phospholipid Scramblase is a newly-identified gene family, whose proteins (PLSCR1-4) were proposed to mediate accelerated transbilayer movement of plasma membrane phospholipids in cells exposed to elevated intracellular Ca2+. The first identified member of this family, PLSCR1, was shown to be a Ca2+-binding endofacial plasma membrane protein that partitions into cholesterol and sphingomyelin-enriched lipid rafts when palmitoylated, and to traffic into the nucleus to influence gene transcription when not palmitoylated. Cellular expression of PLSCR1 is highly induced by the interferons, as well as by various growth factors, and deletion of PLSCR1 results in defective cell maturation and proliferation in response to these same growth factors. Finally, we have evidence that PLSCR1 plays a central role in receptor signaling and transactivation, through its recruitment of the adapter Shc and the activation of c-Src tyrosine kinase. We have now turned our attention to the role of another member of the PLSCR gene family, PLSCR3. Mice with targeted deletion of PLSCR3 show a marked increase in abdominal fat on a standard (~5% fat) diet, with elevated plasma glucose, cholesterol, triglycerides, and free fatty acids relative to WT controls. These mice also show distinctly abnormal glucose tolerance with evidence of insulin resistance, mimicking Metabolic Syndrome in man (obesity-related insulin resistance with dyslipidemia). Adipocytes from these mice are engorged with lipid and show a marked increase in expression of PPAR? and in genes regulated by this nuclear transcription factor. In this Proposal, we aim (1) To determine whether observed lipid engorgement, insulin resistance, and elevation of PPAR? in PLSCR3-/- adipose represent primary defects of PLSCR3 deficiency in the pre-adipocyte; (2): To determine which properties identified or suspected in the case of PLSCR1 are conserved with respect to PLSCR3; (3) To identify the mechanism by which PLSCR3 - through its activity at the plasma membrane or nucleus - attenuates both PPAR? expression and lipid accumulation in the adipocyte. It is proposed that these experiments will provide new insight into the cellular function of PLSCR3 and into a novel class of genes that appear to influence the accumulation of lipid in adipose tissue and the risk for acquiring the Metabolic Syndrome.
描述(由申请人提供):磷脂扰乱酶是一个新鉴定的基因家族,其蛋白质(PLSCR 1 -4)被认为介导暴露于升高的细胞内Ca 2+的细胞中质膜磷脂的加速跨双层运动。该家族的第一个成员PLSCR 1被证明是一种Ca 2+结合的内面质膜蛋白,当棕榈酰化时,其分配到胆固醇和鞘磷脂富集的脂筏中,并且当不棕榈酰化时,其进入细胞核以影响基因转录。PLSCR 1的细胞表达由干扰素以及各种生长因子高度诱导,并且PLSCR 1的缺失导致响应于这些相同生长因子的缺陷性细胞成熟和增殖。最后,我们有证据表明,PLSCR 1在受体信号转导和反式激活中发挥着重要作用,通过其招聘的适配器Shc和激活c-Src酪氨酸激酶。我们现在已经将注意力转向PLSCR基因家族的另一个成员PLSCR 3的作用。PLSCR 3靶向缺失的小鼠在标准(~5%脂肪)饮食下显示腹部脂肪显著增加,相对于WT对照,血浆葡萄糖、胆固醇、甘油三酯和游离脂肪酸升高。这些小鼠还表现出明显异常的葡萄糖耐量,并有胰岛素抵抗的证据,类似于人类的代谢综合征(肥胖相关的胰岛素抵抗伴血脂异常)。这些小鼠的脂肪细胞充满了脂质,并显示出显着增加表达的过氧化物酶体增殖物激活受体?以及受这种核转录因子调控的基因。在本研究中,我们的目的是(1)确定是否观察到的脂质充盈,胰岛素抵抗,和升高的过氧化物酶体增殖物激活物受体?(2):确定在PLSCR 1的情况下鉴定或怀疑的哪些性质相对于PLSCR 3是保守的; (3)为了确定PLSCR 3-通过其在质膜或细胞核的活性-减弱两个PPAR?表达和脂肪细胞中的脂质积累。有人提出,这些实验将提供新的见解PLSCR 3的细胞功能和一类新的基因,似乎影响脂肪组织中的脂质积累和获得代谢综合征的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER J SIMS其他文献

PETER J SIMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER J SIMS', 18)}}的其他基金

Role of PLSCR3 in Adipogenesis & Adipose Lipid Storage
PLSCR3 在脂肪生成中的作用
  • 批准号:
    7194498
  • 财政年份:
    2005
  • 资助金额:
    $ 24.25万
  • 项目类别:
Role of PLSCR3 in Adipogenesis & Adipose Lipid Storage
PLSCR3 在脂肪形成中的作用
  • 批准号:
    7279164
  • 财政年份:
    2005
  • 资助金额:
    $ 24.25万
  • 项目类别:
Role of PLSCR3 in Adipogenesis & Adipose Lipid Storage
PLSCR3 在脂肪生成中的作用
  • 批准号:
    7029339
  • 财政年份:
    2005
  • 资助金额:
    $ 24.25万
  • 项目类别:
PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLASE IN APOPTOSIS
细胞凋亡中的质膜磷脂扰乱
  • 批准号:
    6184448
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
NUCLEAR PL SCRAMBLASE IN DIFFERENTIATION & APOPTOSIS
核电 PL Scramblase 的差异化
  • 批准号:
    7213130
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
NUCLEAR PL SCRAMBLASE IN DIFFERENTIATION & APOPTOSIS
核电 PL Scramblase 的差异化
  • 批准号:
    7447423
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
NUCLEAR PL SCRAMBLASE IN DIFFERENTIATION & APOPTOSIS
核电 PL Scramblase 的差异化
  • 批准号:
    7645728
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLASE IN APOPTOSIS
细胞凋亡中的质膜磷脂扰乱
  • 批准号:
    6537714
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLASE IN APOPTOSIS
细胞凋亡中的质膜磷脂扰乱
  • 批准号:
    6638583
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:
NUCLEAR PL SCRAMBLASE IN DIFFERENTIATION & APOPTOSIS
核电 PL Scramblase 的差异化
  • 批准号:
    7046771
  • 财政年份:
    1999
  • 资助金额:
    $ 24.25万
  • 项目类别:

相似海外基金

Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
  • 批准号:
    MR/Y013891/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
  • 批准号:
    BB/Y006542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
  • 批准号:
    23H03323
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
  • 批准号:
    23K08293
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
  • 批准号:
    479570
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
  • 批准号:
    488898
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
  • 批准号:
    23K19922
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
  • 批准号:
    10605981
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 24.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了